260 related articles for article (PubMed ID: 3250005)
1. Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome.
Ichikawa Y; Takaya M; Uchiyama M; Shimizu H; Tokunaga M; Saitoh H; Arimori S
Tokai J Exp Clin Med; 1988 Jun; 13(2):85-90. PubMed ID: 3250005
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
Gannot G; Lancaster HE; Fox PC
J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sicca symptoms in patients with Sjögren's syndrome, and reports of six cases lacking subjective sicca features ("subclinical Sjögren's syndrome").
Ichikawa Y; Takaya M; Saitoh H
Tokai J Exp Clin Med; 1981 Jul; 6(3):229-40. PubMed ID: 7303004
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
6. Validity of screening tests for Sjögren's syndrome in ambulatory patients with chronic diseases.
Sánchez-Guerrero J; Pérez-Dosal MR; Celis-Aguilar E; Cárdenas-Velázquez F; Soto-Rojas AE; Avila-Casado C
J Rheumatol; 2006 May; 33(5):907-11. PubMed ID: 16541477
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
8. Tear fluid proteins in Sjögren's syndrome.
Janssen PT; van Bijsterveld OP
Scand J Rheumatol Suppl; 1986; 61():224-7. PubMed ID: 3473637
[TBL] [Abstract][Full Text] [Related]
9. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome.
Lee M; Rutka JA; Slomovic AR; McComb J; Bailey DJ; Bookman AA
J Rheumatol; 1998 Feb; 25(2):247-53. PubMed ID: 9489815
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
11. [Primary Sjögren's syndrome--more than a dry mouth and dry eyes].
Magnus JH; Omdal R; Hinderaker W; Husby G
Nord Med; 1990; 105(10):262-3. PubMed ID: 2235472
[TBL] [Abstract][Full Text] [Related]
12. Potential involvement of subclinical Sjögren's syndrome in various lung diseases.
Kurumagawa T; Kobayashi H; Motoyoshi K
Respirology; 2005 Jan; 10(1):86-91. PubMed ID: 15691243
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome. Controversies and progress.
Fox RI
Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of 117 patients with Sjögren's syndrome.
Ichikawa Y; Takaya M; Yamauchi K; Shimizu Y; Koriyama K; Arimori S
Tokai J Exp Clin Med; 1981 Jan; 6(1):11-22. PubMed ID: 7256792
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
17. [Salivary immunoglobulins in the diagnosis of primary Sjögren's syndrome].
Bianucci GF; Campana G; Maddali Bongi S; Palermo C; Castagnoli A
Minerva Med; 1993 Apr; 84(4):161-70. PubMed ID: 8506054
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and early diagnosis of Sjögren syndrome.
Kassan SS; Moutsopoulos HM
Arch Intern Med; 2004 Jun; 164(12):1275-84. PubMed ID: 15226160
[TBL] [Abstract][Full Text] [Related]
20. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
